MyJournals Home  
All
Andrology
Astronomy
Biochemistry
Bioinformatics
Biology
Biophysics
Biotechnology
Botany
Cardiology
Cell Biology
Chemistry
Dermatology
Ecology
Epidemiology
Evolutionary Biology
General
Genetics
Genomics
Geology
Geriatrics
Gynaecology
Immunology
Informatics
Mathematics
Medicine
Microbiology
Molecular Biology
Neurology
Nutrition
Oncology
Pathology
Pediatrics
Pharmacology
Philosophy
Physics
Physiology
Psychiatry
Psychology
Statistics
Surgery
Toxicology
Urology
Virology
Zoology

RSS FeedsValidating ORR and PFS as surrogate endpoints in phase II and III clinical trials for NSCLC patients: difference exists in the strength of surrogacy in various trial settings (BMC Cancer)

 
 

29 september 2022 22:09:53

 
Validating ORR and PFS as surrogate endpoints in phase II and III clinical trials for NSCLC patients: difference exists in the strength of surrogacy in various trial settings (BMC Cancer)
 
This study aims to systematically validate the performance of surrogate endpoints in phase II and III clinical trials for NSCLC patients under various trial settings.


 
107 viewsCategory: Oncology
 
Proteomics profiling identifies extracellular vesicles` cargo associated with tumour cell induced platelet aggregation (BMC Cancer)
Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study (BMC Cancer)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten